Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
04/2014
04/03/2014US20140094448 Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
04/03/2014US20140093453 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
04/02/2014EP2712358A2 Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
04/02/2014CN103703174A Combination pharmaceutical compositions and uses thereof
04/02/2014CN103703005A Tricyclic inhibitors of kinases
04/02/2014CN103703004A Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as parp inhibitors
04/02/2014CN103703003A Novel compounds for organic electronic material and organic electroluminescent device using the same
04/02/2014CN103703002A Novel compound having parp inhibitory activity
04/02/2014CN103703001A Quinazolines as therapeutic compounds and related methods of use
04/02/2014CN103702999A Cyclic p1 linkers as factor xia inhibitors
04/02/2014CN103702989A Novel compounds as modulators of protein kinases
04/02/2014CN103702686A Methods of preparation of conjugates
04/02/2014CN103694246A Preparation method of A3B type asymmetric porphyrin compounds
04/02/2014CN103694245A Crude medicine for hypoglycemic medicine
04/02/2014CN103694244A 3, 6 substituted-1, 2, 4-triazole [3, 4-alpha] phthalazine compound as well as preparation method and application of 3, 6 substituted-1, 2, 4-triazole [3, 4-alpha] phthalazine compound
04/02/2014CN103694243A 2-substituted pyridyl-1,2,4-triazol [1,2-a] pyridazine compound
04/02/2014CN103694242A Pyrazolopyrimidine compound and pharmaceutical composition thereof as well as pharmaceutical application of pyrazolopyrimidine compound
04/02/2014CN103694241A Novel crystal form A of PCI-32765 and preparation method thereof
04/02/2014CN103694240A Solvate of lixivaptan and preparation method and application thereof
04/02/2014CN103694236A Novel antineoplastic compound containing pyrimidine skeleton and hedgehog pathway antagonist activity
04/02/2014CN103694163A Compounds capable of being adopted as potassium channel modulators
04/02/2014CN102712623B Hepatitis c virus inhibitors
04/02/2014CN102675625B Preparation method for water-solubility metal phthalocyanine derivative
04/02/2014CN102603748B Carbazole-based high-condensed ring dinitrogen-aza[7]helicene compound and synthetic method thereof
04/02/2014CN102356109B Inclusion complex, curing agent, cure accelerator, epoxy resin composition, and epoxy resin composition for encapsulation of semiconductor
04/02/2014CN102199102B Sitagliptin intermediate and preparation method and application thereof
04/02/2014CN102143750B Macrocyclics pyrimidines as aurora kinase inhibitors
04/01/2014US8686140 Method of purifying a salt, sodium salt and disodium salt of pemetrexed
04/01/2014US8686139 Organic electronic device comprising an organic semiconducting material
04/01/2014US8686134 Ionic liquids
04/01/2014US8686020 Spirocyclic compounds
04/01/2014US8685988 EGFR modulators and uses thereof
04/01/2014US8685987 Substituted [1,2,4]triazolo[1,5-a]pyrimidines and their use as potassium channel modulators
04/01/2014US8685980 Pyrrolopyrimidine compounds and their uses
04/01/2014US8685969 Carboline carboxamide compounds useful as kinase inhibitors
04/01/2014CA2648019C Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
03/2014
03/27/2014WO2014047413A1 Novel gabaa agonists and methods of using to control airway hyperresponsiveness and inflammation in asthma
03/27/2014WO2014047390A1 Tricyclic heterocyclic compounds as notch inhibitors
03/27/2014WO2014047328A2 Pkc delta inhibitors for use as therapeutics
03/27/2014WO2014047024A1 Iap antagonists
03/27/2014WO2014047020A1 Dihydropyrrolidino-pyrimidines as kinase inhibitors
03/27/2014WO2014045310A1 Pyrimido[5,4-d]pyrimidine or pyrimidine derivatives compounds and uses thereof in the treatment of cancer
03/27/2014WO2014045305A1 Substituted fused tricyclic compounds, compositions and medicinal applications thereof
03/27/2014WO2014045101A1 Tetrazolo quinoxaline derivatives as tankyrase inhibitors
03/27/2014WO2014045029A1 2-(2-aminocyclohexyl)amino-pyrimidine-5-carboxamides as spleen tyrosine kinasei(syk) inhibitors
03/27/2014WO2014044738A1 Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators
03/27/2014WO2014044722A1 Azadibenzofurans for electronic applications
03/27/2014WO2014044691A1 Substituted pyrrolopyrimidinylamino-benzothiazolones as mknk kinase inhibitors
03/27/2014WO2014044356A1 Hydropyrrolopyrrole derivatives for use as fatty acid synthase inhibitors
03/27/2014WO2014044025A1 Pyrimidineamide derivative and preparation method and use thereof
03/27/2014WO2014043860A1 Soluble phthalocyanine compound and preparation method thereof, and organic thin film transistor
03/27/2014WO2014022378A3 Naphthobisazole diimide based n-tvpe organic semiconductors
03/27/2014WO2014019908A3 Substituted pyrroles active as kinases inhibitors
03/27/2014US20140088166 Process of making and using pharmaceutical formulations of antineoplastic agents
03/27/2014US20140088110 Fused bicyclic imidazoles
03/27/2014US20140088109 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
03/27/2014US20140088100 Inhibitors of the fibroblast growth factor receptor
03/27/2014US20140088099 Chemical compounds, compositions and methods for kinase modulation
03/27/2014US20140088096 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
03/27/2014US20140088089 Cytotoxic benzodiazepine derivatives and methods of preparation
03/27/2014US20140088087 Azepino[4,5-b]indoles and methods of use
03/27/2014US20140088086 Compounds and methods for treatment of hypertension
03/27/2014US20140088085 Substituted Benzoazepines As Toll-Like Receptor Modulators
03/27/2014US20140088081 Amino-Heterocyclic Compounds
03/27/2014US20140086870 Pyrazole derivatives as jak inhibitors
03/26/2014EP2710023A2 Purine monophosphate prodrugs for treatment of viral infections
03/26/2014EP2710007A2 Kinase inhibitors
03/26/2014EP2710006A1 Azaindole derivatives as tyrosine kinase inhibitors
03/26/2014EP2710005A1 Tyrosine kinase inhibitors
03/26/2014EP2710004A1 Amino-substituted imidazopyridazines as mknk1 kinase inhibitors
03/26/2014EP2710003A1 Fused bicyclic kinase inhibitors
03/26/2014EP2709984A1 New hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
03/26/2014EP2709451A1 N-linked lactam m1 receptor positive allosteric modulators
03/26/2014CN103687866A Purine monophosphate prodrugs for treatment of viral infections
03/26/2014CN103687858A Amino-substituted imidazopyridazines as MKNK1 kinase inhibitors
03/26/2014CN103687623A Cytotoxic benzodiazepine derivatives
03/26/2014CN103665339A Diketopyrrolopyrrole-base polymer, and preparation method and application thereof
03/26/2014CN103665005A Amido bond symmetrical molecular tweezers-containing series of porphyrin compounds and preparation method thereof
03/26/2014CN103665004A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664996A Indole derivative and preparation method thereof
03/26/2014CN103664966A Method for preparing asymmetric 5,15-bis(p-nitrophenyl)-10, 20-diphenyl porphyrin compound
03/26/2014CN103664965A Method for preparing phthalocyanine micro-nano structure
03/26/2014CN103664964A Absorption method and device for rectified gas production from TEDA (triethylene diamine)
03/26/2014CN103664963A Method for synthesizing quinazolino indazole derivatives
03/26/2014CN103664962A Piperazines derivative
03/26/2014CN103664961A Synthetic process of sildenafil
03/26/2014CN103664960A Preparation method for Ponatinib
03/26/2014CN103664959A Preparation method of five-membered bicyclic guanidine compounds
03/26/2014CN103664958A Crystal form of ticagrelor and preparation method for crystal form
03/26/2014CN103664957A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664956A New crystal form of ticagrelor and preparation method thereof
03/26/2014CN103664955A New crystal form of ticagrelor and preparation method thereof
03/26/2014CN103664954A Compounds for treating traumatic brain injury diseases and application thereof
03/26/2014CN103664953A Preparation method of eszopiclone
03/26/2014CN103664952A Preparation method of zopiclone
03/26/2014CN103664951A Preparation method of drug for treating chronic granulocytic leukemia
03/26/2014CN103664950A Novel trimerization carbazole based narrow band gap conjugated micromolecule material and preparation method thereof
03/26/2014CN103664907A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664883A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664799A Compounds for treating narrow chamber angle and application thereof
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 573